This inventor holds 23 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 6 EPO patents, primarily in Cancer Detection Methods. Top assignees: Abbott Laboratories Corporation, Abbott Molecular Inc.. Active years: 1998-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998-2020
Areas of Expertise:
Title: Innovator Tracey L Colpitts: Pioneering Cancer Assessment Technologies
Introduction: Tracey L Colpitts, based in Round Lake, Illinois, is a notable inventor with a remarkable portfolio of 23 patents. His innovative contributions are primarily focused on the assessment and progression of prostate cancer, illustrating his commitment to advancing medical diagnostics.
Latest Patents: Among his latest patents, Colpitts has developed groundbreaking materials and methods for assessing the progression of prostate cancer. These inventions include methods for distinguishing and identifying patients with aggressive or indolent prostatic adenocarcinoma. The processes involve contacting a sample from the patient with a set of detectably labeled probes under hybridization conditions, followed by determining the presence of chromosomal abnormalities in the sample. His patents also include sets of probes designed for these methods and comprehensive kits that comprise a set of probes along with instructions aimed at identifying or distinguishing patients diagnosed with aggressive or indolent forms of prostatic adenocarcinoma.
Career Highlights: Tracey L Colpitts has a distinguished career, having worked at reputable companies such as Abbott Laboratories Corporation and Abbott Molecular Inc. His experience at these organizations has enabled him to refine his expertise in diagnostics and cancer research.
Collaborations: Throughout his career, Colpitts has collaborated with remarkable professionals in the field, including John C Russell and Maurice Cohen. These partnerships have further enriched his contributions to cancer research and innovation.
Conclusion: Tracey L Colpitts continues to make significant strides in the realm of medical diagnostics, particularly related to prostate cancer. His impressive portfolio of patents not only reflects his innovative spirit but also his dedication to improving patient outcomes through advanced technology and research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile